ID BIONi010-C-38 AC CVCL_UR27 SY BIONi010-C Swedish (KM670/671NL); APP KM670/671NL DR hPSCreg; BIONi010-C-38 DR Wikidata; Q93426795 RX PubMed=30634129; CC From: Bioneer A/S; Horsholm; Denmark. CC Population: African. CC Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Lys670_Met671delinsAsnLeu (c.2010_2011inv) (c.2010_2011delGAinsTC); ClinVar=VCV000018093; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=30634129). CC Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067. CC Cell type: Fibroblast of skin; CL=CL_0002620. DI NCIt; C146894; Alzheimer's disease 1 DI ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_1E68 ! BIONi010-C SX Male AG 18Y CA Induced pluripotent stem cell DT Created: 25-02-19; Last updated: 10-04-25; Version: 12 // RX PubMed=30634129; DOI=10.1016/j.scr.2018.101368; RA Frederiksen, Henriette Reventlow Secher RA Holst, Bjorn RA Ramakrishna, Sarayu RA Muddashetty, Ravi S. RA Schmid, Benjamin RA Freude, Kristine Karla RT "Generation of two iPSC lines with either a heterozygous V717I or a RT heterozygous KM670/671NL mutation in the APP gene."; RL Stem Cell Res. 34:101368-101368(2019). //